Abstract:Gastric cancer is the leading cause of cancer-related mortality across the world, with poor prognosis and a median overall survival of ≤12 months for advanced stage gastric cancer. Environmental, genetic and other predisposing factors contribute to the development of gastric cancer and a predominant factor was found to be infection of <i>Helicobacter pylori</i> Advances in understanding the deranged signalling pathways that are critical for normal cellular homeostasis helped in the development of novel drugs that target specific proteins and pathways to curtail the growth of gastric cancer. Genetic studies revealed several single nucleotide polymorphisms, chromosomal aberrations and epigenetic alterations that likely play a major role in elevating the susceptibility to develop gastric cancer. Methylation pattern of specific genes may likely prove to be a valid biomarker for early detection of gastric cancer, but much progress is needed to establish specific markers. Important developments have been made in targeting human epidermal growth factor receptor-2 and vascular endothelial growth factor receptor 2 for treating advanced gastro-oesophageal junction cancer, using specific monoclonal antibodies. Lack of efficacy with regard to targeting other signalling pathways including mesenchymal-epithelial transition/hepatocyte growth factor and mammalian target of rapamycin is probably due to suboptimal patient selection for these clinical trials, which is probably due to the lack of appropriate biomarkers, to decide on responsive patient population. Besides the development of antagonists for the cell growth-related signalling pathways, advances are also being made to tackle gastric cancer by immunotherapies, targeting immune check-points, which may hold promise for better treatment options in future.

Advancement of Gene Diagnosis and Gene Therapy on Gastric Cancer

Research Progress on Oncogene, Suppressor Gene andtheir Products in Gastric Carcinoma

Advance in Gene Therapy of Tumors

Progress in the clinical research of gastric cancer

Section Review—Oncologic, Endocrine & Metabolic: Gene Therapy Strategies for Cancer

Research Status and Progress on Treatment of Advanced Gastric Cancer

Advancement and prospects of tumor gene therapy

Advances in research on molecular mechanisms and target diagnosis of gastric cancer

Advance and Prospects of Nanotheranostic Technology for Gastric Cancer

Recent Advances in the Diagnosis, Staging, Treatment, and Prognosis of Advanced Gastric Cancer: A Literature Review

Advances in molecular targeted therapy for gastric cancer

Biomarkers for gastric cancer: Progression in early diagnosis and prognosis (Review).

Gastric cancer: somatic genetics as a guide to therapy

Current therapies and progress in the treatment of advanced gastric cancer

Advancements of gene therapy in cancer treatment: A comprehensive review

Review of recent efforts to discover biomarkers for early detection, monitoring, prognosis, and prediction of treatment responses of patients with gastric cancer

Advances in Targeted Treatment for Gastric Cancer

Clinical progress of anti-angiogenic targeted therapy and combination therapy for gastric cancer

Therapeutic Potential of Gene Therapy for Gastrointestinal Diseases: Advancements and Future Perspectives

Pancreatic Cancer: Gene Therapy Approaches and Gene Delivery Systems.

Current Molecular Targeted Therapy in Advanced Gastric Cancer: A Comprehensive Review of Therapeutic Mechanism, Clinical Trials, and Practical Application